Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Chytil

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2011
Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacyTomáš Etrych, Lubomír Kovář, Jiří Strohalm, et al.
Molecular Pharmaceutics|March 16, 2018
Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug ReleasePetr Chytil, Milada Šírová, Júlia Kudláčová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2008
Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targetingTomás Etrych, Petr Chytil, Tomás Mrkvan, et al.
Journal of Drug Targeting|July 21, 2017
Polymer donors of nitric oxide improve the treatment of experimental solid tumours with nanosized polymer therapeuticsMilada Šírová, Veronika Horková, Tomáš Etrych, et al.
International Journal of Molecular Sciences|August 23, 2020
Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and MicroenvironmentAnne-Kathrin Noack, Henrike Lucas, Petr Chytil, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 26, 2013
Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkageHideaki Nakamura, Tomas Etrych, Petr Chytil, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 13, 2016
The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxelMilada Šírová, Jiří Strohalm, Petr Chytil, et al.
International Journal of Pharmaceutics: X|January 26, 2026
HPMA polymers as functional excipients in dermal nanoformulations of imiquimodEliška Kurfiřtová, Stanislav Chvíla, Nikola Strnádková, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 11, 2006
Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modificationPetr Chytil, Tomás Etrych, Cestmír Konák, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 3, 2014
Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing miceHideaki Nakamura, Eva Koziolová, Tomáš Etrych, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2011
Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacyTomáš Etrych, Lubomír Kovář, Jiří Strohalm, et al.
Molecular Pharmaceutics|March 16, 2018
Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug ReleasePetr Chytil, Milada Šírová, Júlia Kudláčová, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2008
Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targetingTomás Etrych, Petr Chytil, Tomás Mrkvan, et al.
Journal of Drug Targeting|July 21, 2017
Polymer donors of nitric oxide improve the treatment of experimental solid tumours with nanosized polymer therapeuticsMilada Šírová, Veronika Horková, Tomáš Etrych, et al.
International Journal of Molecular Sciences|August 23, 2020
Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and MicroenvironmentAnne-Kathrin Noack, Henrike Lucas, Petr Chytil, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 26, 2013
Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkageHideaki Nakamura, Tomas Etrych, Petr Chytil, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 13, 2016
The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxelMilada Šírová, Jiří Strohalm, Petr Chytil, et al.
International Journal of Pharmaceutics: X|January 26, 2026
HPMA polymers as functional excipients in dermal nanoformulations of imiquimodEliška Kurfiřtová, Stanislav Chvíla, Nikola Strnádková, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 11, 2006
Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modificationPetr Chytil, Tomás Etrych, Cestmír Konák, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 3, 2014
Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing miceHideaki Nakamura, Eva Koziolová, Tomáš Etrych, et al.
Pageof 6